Stockreport

ALX Oncology Holdings Inc (ALXO) Q4 2025 Earnings Call Highlights: Strong Clinical Progress and ... [Yahoo! Finance]

ALX Oncology Holdings Inc.  (ALXO) 
PDF This article first appeared on GuruFocus Cash Equivalents and Investments: $48.3 million as of the end of Q4 2025. Net Proceeds from Equity Financing: $140.4 millio [Read more]